Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rises as oil slide offers respite after Fed rate hike
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Paradium AI (PAAI) Halted, News Pending
DA Davidson Starts monday.com Ltd. (MNDY) at Neutral
November 12, 2024 5:23 AM ESTDA Davidson analyst Lucky Schreiner initiates coverage on monday.com Ltd. (NASDAQ: MNDY) with a Neutral rating and a price target of $300.00.
The analyst comments "With this note, we are assuming coverage of monday.com with a NEUTRAL rating and $300 price target.... More
JPMorgan Defending monday.com Ltd. (MNDY)
November 11, 2024 4:06 PM ESTJPMorgan analyst Pinjalim Bora reiterated an Overweight rating and $350.00 price target on monday.com Ltd. (NASDAQ: MNDY).
The analyst comments "Monday reported a fine quarter in a choppy macro backdrop, with all key guided metrics landing ahead of consensus expectations as Monday marked a Rule of 65% quarter, in addition to the full year guide being reset higher. However, the beat-and-raise magnitude softened relative to historical norms and likely landed towards the low end of buy-side bars, making it challenging for... More
